Arkansas Legal Resource Navigator

42 U.S.C. § 285b–4 — National research and demonstration centers

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 285b–4 — National research and demonstration centers

**(a) Heart, blood vessel, lung, blood diseases, and blood resources; utilization of centers for prevention programs** (1) The Director of the Institute may provide, in accordance with subsection (c), for the development of— (A) ten centers for basic and clinical research into, training in, and demonstration of, advanced diagnostic, prevention, and treatment and rehabilitation methods (including methods of providing emergency medical services) for heart and blood vessel diseases; (B) ten centers for basic and clinical research into, training in, and demonstration of, advanced diagnostic, prevention, and treatment and rehabilitation methods (including methods of providing emergency medical services) for lung diseases (including bronchitis, emphysema, asthma, cystic fibrosis, and other lung diseases of children); (C) ten centers for basic and clinical research into, training in, and demonstration of, advanced diagnostic, prevention, and treatment methods (including methods of providing emergency medical services) for blood diseases and research into blood, in the use of blood products and in the management of blood resources; and (D) three centers for basic and clinical research into, training in, and demonstration of, advanced diagnostic, prevention, and treatment (including genetic studies, intrauterine environment studies, postnatal studies, heart arrhythmias, and acquired heart disease and preventive cardiology) for cardiovascular diseases in children. (2) The centers developed under paragraph (1) shall, in addition to being utilized for research, training, and demonstrations, be utilized for the following prevention programs for cardiovascular, pulmonary, and blood diseases: (A) Programs to develop improved methods of detecting individuals with a hig

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 285b–4

Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: a3643581cf174a3540be9aed7123cec8bf14056679e081b1a85bb67c07aafeb1. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Record provenance

Stable record: federal_law:legal_authorities:record_usc_25553a880beba67af721916c
Source file: Laws/federal/codes/united-states-code/title-42/section-285b4-national-research-and-demonstration-centers--e01b655d4a.md
Pages: Not recorded – Not recorded
Passage SHA-256: 754fcb8b5c1cca0737f9234eef409b0d51863b272b2678cb1d99a7ac42b402ab

Source location: Title 42, Chapter 6A, § 285b–4; chapter-6a-public-health-service.md

Stored source content

**(a) Heart, blood vessel, lung, blood diseases, and blood resources; utilization of centers for prevention programs** (1) The Director of the Institute may provide, in accordance with subsection (c), for the development of— (A) ten centers for basic and clinical research into, training in, and demonstration of, advanced diagnostic, prevention, and treatment and rehabilitation methods (including methods of providing emergency medical services) for heart and blood vessel diseases; (B) ten centers for basic and clinical research into, training in, and demonstration of, advanced diagnostic, prevention, and treatment and rehabilitation methods (including methods of providing emergency medical services) for lung diseases (including bronchitis, emphysema, asthma, cystic fibrosis, and other lung diseases of children); (C) ten centers for basic and clinical research into, training in, and demonstration of, advanced diagnostic, prevention, and treatment methods (including methods of providing emergency medical services) for blood diseases and research into blood, in the use of blood products and in the management of blood resources; and (D) three centers for basic and clinical research into, training in, and demonstration of, advanced diagnostic, prevention, and treatment (including genetic studies, intrauterine environment studies, postnatal studies, heart arrhythmias, and acquired heart disease and preventive cardiology) for cardiovascular diseases in children. (2) The centers developed under paragraph (1) shall, in addition to being utilized for research, training, and demonstrations, be utilized for the following prevention programs for cardiovascular, pulmonary, and blood diseases: (A) Programs to develop improved methods of detecting individuals with a high risk of developing cardiovascular, pulmonary, and blood diseases. (B) Programs to develop improved methods of intervention against those factors which cause individuals to have a high risk of developing such diseases. (C) Programs to develop health professions and allied health professions personnel highly skilled in the prevention of such diseases. (D) Programs to develop improved methods of providing emergency medical services for persons with such diseases. (E) Programs of continuing education for health and allied health professionals in the diagnosis, prevention, and treatment of such diseases and the maintenance of health to reduce the incidence of such diseases and information programs for the public respecting the prevention and early diagnosis and treatment of such diseases and the maintenance of health. (3) The research, training, and demonstration activities carried out through any such center may relate to any one or more of the diseases referred to in paragraph (1) of this subsection. **(b) Sickle cell anemia** The Director of the Institute shall provide, in accordance with subsection (c), for the development of ten centers for basic and clinical research into the diagnosis, treatment, and control of sickle cell anemia. **(c) Cooperative agreements and grants for establishing and supporting; uses for Federal payments; period of support, additional periods** (1) The Director of the Institute may enter into cooperative agreements with and make grants to public or private nonprofit entities to pay all or part of the cost of planning, establishing, or strengthening, and providing basic operating support for centers for basic and clinical research into, training in, and demonstration of the management of blood resources and advanced diagnostic, prevention, and treatment methods for heart, blood vessel, lung, or blood diseases. (2) A cooperative agreement or grant under paragraph (1) shall be entered into in accordance with policies established by the Director of NIH and after consultation with the Institute’s advisory council. (3) Federal payments made under a cooperative agreement or grant under paragraph (1) may be used for— (A) construction (notwithstanding any limitation under [section 289e of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section289e&num=0&edition=prelim)); (B) staffing and other basic operating costs, including such patient care costs as are required for research; (C) training, including training for allied health professionals; and (D) demonstration purposes. As used in this subsection, the term “construction” does not include the acquisition of land, and the term “training” does not include research training for which Ruth L. Kirschstein National Research Service Awards may be provided under [section 288 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section288&num=0&edition=prelim). (4) Support of a center under paragraph (1) may be for a period of not to exceed five years. Such period may be extended by the Director for additional periods of not more than five years each if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director and if such group has recommended to the Director that such period should be extended.

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 288 — Ruth L. Kirschstein National Research Service Awards

**(a) Biomedical and behavioral research and research training; programs and institutions included; restriction; special consideration** (1) The Secretary shall— (A) provide Ruth L. Kirschstein National Research Service Awards for— (i) biomedical and behavioral research at the National Institutes of Health in matters relating to the cause, diagnosis, prevention, and treatment of the diseases or other health problems to which the activities of the National Institutes of Health and Administration 11 So in original. Reference to Administration probably should not appear. are directed; (ii) training at the National Institutes of Health and at the Administration 1 of individuals to undertake such research; (iii) biomedical and behavioral research and health services research (including research in primary medical care) at public and nonprofit private entities; and (iv) pre-doctoral and post-doctoral training at public and private institutions of individuals to undertake biomedical and behavioral research; (B) make grants to public and nonprofit private institutions to enable such institutions to make Ruth L. Kirschstein National Research Service Awards for research (and training to undertake biomedical and behavioral research) in the matters described in subparagraph (A)(i) to individuals selected by such institutions; and (C) provide contracts for scholarships and loan repayments in accordance with sections 288–4 and 288–5 22 See References in Text note below. of this title, subject to providing not more than an aggregate 50 such contracts during the fiscal years 1994 through 1996. A reference in this subsection to the National Institutes of Health shall be considered to include the institutes, agencies, divisions, and bureaus included in the

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 288

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 289e — Use of appropriations

**(a)** Appropriations to carry out the purposes of this subchapter, unless otherwise expressly provided, may be expended in the District of Columbia for— (1) personal services; (2) stenographic recording and translating services; (3) travel expenses (including the expenses of attendance at meetings when specifically authorized by the Secretary); (4) rental; (5) supplies and equipment; (6) purchase and exchange of medical books, books of reference, directories, periodicals, newspapers, and press clippings; (7) purchase, operation, and maintenance of passenger motor vehicles; (8) printing and binding (in addition to that otherwise provided by law); and (9) all other necessary expenses in carrying out this subchapter. Such appropriations may be expended by contract if deemed necessary, without regard to [section 6101 of title 41](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title41-section6101&num=0&edition=prelim). **(b)** (1) None of the amounts appropriated under this chapter for the purposes of this subchapter may be obligated for the construction of facilities (including the acquisition of land) unless a provision of this subchapter establishes express authority for such purpose and unless the Act making appropriations under such provision specifies that the amounts appropriated are available for such purpose. (2) Any grants, cooperative agreements, or contracts authorized in this subchapter for the construction of facilities may be awarded only on a competitive basis.

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 289e

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.